Literature DB >> 28210393

Has Vitamin D Had Its "Time In The Sun" For Melanoma?

Christopher J Huerter1, Adam Vaudreuil1, Devendra K Agrawal1, Austin Huy Nguyen1.   

Abstract

Growing evidence suggests a pivotal role for vitamin D in cancers, particularly melanoma. The broad immunologic effects of vitamin D and its signaling axis make for a complex interplay between tumor cells and the immune system. Preclinical evidence suggests vitamin D to have protective effects in melanoma oncogenesis and progression, creating a potential role for vitamin D supplementation in cancer prevention and/or adjuvant therapy. In this commentary, the authors highlight studies of vitamin D in melanoma with clinical implications and call for large clinical trials to definitively determine the role of supplementation in patients to prevent and help treat melanoma.

Entities:  

Year:  2016        PMID: 28210393      PMCID: PMC5300721     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  14 in total

1.  Vitamin D and immune function: understanding common pathways.

Authors:  Daniel D Bikle
Journal:  Curr Osteoporos Rep       Date:  2009-07       Impact factor: 5.096

2.  Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma.

Authors:  Rochelle Mandelcorn-Monson; Loraine Marrett; Anne Kricker; Bruce K Armstrong; Irene Orlow; Chris Goumas; Susan Paine; Stefano Rosso; Nancy Thomas; Robert C Millikan; Jason D Pole; Javier Cotignola; Cheryl Rosen; Peter A Kanetsky; Julia Lee-Taylor; Colin B Begg; Marianne Berwick
Journal:  Cancer Epidemiol       Date:  2011-05-25       Impact factor: 2.984

3.  Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers.

Authors:  William B Grant
Journal:  J Photochem Photobiol B       Date:  2010-05-12       Impact factor: 6.252

4.  Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression.

Authors:  Anna A Brożyna; Wojciech Jóźwicki; Zorica Janjetovic; Andrzej T Slominski
Journal:  Hum Pathol       Date:  2012-09-17       Impact factor: 3.466

5.  Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients.

Authors:  B Nürnberg; S Gräber; B Gärtner; J Geisel; C Pföhler; D Schadendorf; W Tilgen; J Reichrath
Journal:  Anticancer Res       Date:  2009-09       Impact factor: 2.480

Review 6.  Vitamin D and skin cancer.

Authors:  Erin M Burns; Craig A Elmets; Nabiha Yusuf
Journal:  Photochem Photobiol       Date:  2014-12-08       Impact factor: 3.421

Review 7.  The vitamin D questions: how much do you need and how should you get it?

Authors:  Deon Wolpowitz; Barbara A Gilchrest
Journal:  J Am Acad Dermatol       Date:  2006-01-04       Impact factor: 11.527

8.  Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.

Authors:  Julia A Newton-Bishop; Samantha Beswick; Juliette Randerson-Moor; Yu-Mei Chang; Paul Affleck; Faye Elliott; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Kairen Kukalizch; Linda Whitaker; Sharon Jackson; Edwina Gerry; Clarissa Nolan; Chandra Bertram; Jerry Marsden; David E Elder; Jennifer H Barrett; D Timothy Bishop
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

9.  Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial.

Authors:  Maria V Grau; John A Baron; Robert S Sandler; Robert W Haile; Michael L Beach; Timothy R Church; David Heber
Journal:  J Natl Cancer Inst       Date:  2003-12-03       Impact factor: 13.506

10.  Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.

Authors:  Pentti Tuohimaa; Leena Tenkanen; Merja Ahonen; Sonja Lumme; Egil Jellum; Göran Hallmans; Pär Stattin; Sverre Harvei; Timo Hakulinen; Tapio Luostarinen; Joakim Dillner; Matti Lehtinen; Matti Hakama
Journal:  Int J Cancer       Date:  2004-01-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.